Biotech Stocks
Biotech filings and news · newest 9:00 AM ET · How scores work
Fri, Oct 96 events
7MLYSMineralys Therapeutics, Inc.Lorundrostat Hits 46% SBP Control in Resistant Hypertension, Expands OSA Data7ATOSAtossa Therapeutics, Inc.Atossa Executes CVR Deal: Shareholders Get 25% of Priority Review Voucher Proceeds7QNCXQuince Therapeutics, Inc.Quince Therapeutics Names Brigette Roberts CEO Amid Restructuring8QNCXQuince Therapeutics, Inc.Quince Therapeutics Rebrands as IRulya Therapeutics with New Leadership and $116M Cash Runway Through 20287SPTXSeaport Therapeutics, Inc.GlyphAgo Phase 1 PK Shows 6.8x Bioavailability, 10x Lower Variability7ALMSALUMIS INC.Envudeucitinib Shows Rapid, Durable Relief Across Scalp, Itch, and Quality of Life in Phase 3
Thu, Oct 829 events
8PHVSPharvaris N.V.Pharvaris' Deucrictibant Phase 3 Data Published in The Lancet, Showing Rapid HAE Attack Resolution8PPCBPropanc Biopharma, Inc.Propanc Biopharma Approves Reverse Stock Split to Preserve Nasdaq Listing7NWBONorthwest Biotherapeutics IncNW Bio Partners with UK NHS Blood and Transplant to Scale DCVax-L Production8FBLGFibroBiologics, Inc.FibroBiologics Sells $1.2M Convertible Debenture at 15% Discount to Peak One8FULCFulcrum Therapeutics, Inc.Fulcrum S-4 Amendment Adds HSR Clearance and Slate Phase 1 Trial Launch to Reverse Merger8PASGPassage BIO, Inc.Passage Bio Sets Nov 5 Vote on Remix Merger; Net Cash Estimate Rises to $10.9M8PCVXVaxcyte, Inc.Vaxcyte Finalizes $500M Equity Offering at $64/Share Alongside $500M Convertible Notes9JAGXJaguar Health, Inc.Jaguar Health Seeks Approval for Up to 92.9% Dilution, Reverse Split, and ELOC Floor Price Cut7TENXTenax Therapeutics, Inc.Tenax Pauses LEVEL-2 Enrollment to Amend Protocol After LEVEL Data7QSIQuantum-Si IncProteus Platform Reaches 19 Amino Acids, Closing In on Full 20-Amino-Acid Detection8TRAWTraws Pharma, Inc.Traws Pharma Seeks Stockholder Approval for 1-for-8 to 1-for-15 Reverse Split to Regain Nasdaq Compliance7LTRNLantern Pharma Inc.Lantern Pharma Seeks Approval to Double Authorized Shares and Issue 3.67M Warrant Shares7QSIQuantum-Si IncQuantum-Si's Proteus Hits 19 Amino Acids, Targets All 20 by Year-End9BOLDBoundless Bio, Inc.Boundless Bio Files S-4 for Reverse Merger with Serapha Bio: 96.2% Dilution, $44-48M Dividend, and Beam Litigation Risk7XRTXXORTX Therapeutics Inc.XORTX Adds Health Canada CTA Filing to Gout Program, Accelerating Global Regulatory Push7TVGNTevogen Inc.Tevogen Signs LOI to Explore HRK Healthcare Acquisition, Eyes $100M Revenue7ADCTADC Therapeutics SAADC Therapeutics Unveils Strategic Financial Restructuring to Strengthen Capital Structure7VIRVir Biotechnology, Inc.FDA Grants Fast Track to Vir's VIR-5500 for Late-Line Prostate Cancer7SRRKScholar Rock Holding CorpScholar Rock Resubmits Apitegromab MAA to EMA, Eyes CHMP Opinion in H1 20278AGENAgenus Inc.Armenia Grants First-Ever Marketing Authorizations for Agenus' BOT+BAL in MSS Colorectal Cancer7EDITEditas Medicine, Inc.Editas Medicine Cleared to Start First-in-Human Trial of EDIT-401 for Hyperlipidemia7XFORX4 Pharmaceuticals, IncX4 Pharmaceuticals Secures Up to $150M Debt Facility, Repays Prior Loan7EDITEditas Medicine, Inc.Editas Wins Approval to Start First-In-Human Trial of Gene-Editing Therapy EDIT-4017RNAAtrium Therapeutics, Inc.Atrium Therapeutics Prices $50M PIPE at $7.93/Share, Extends Runway Through 20288ARGXARGENX SEArgenx Halts Phase 3 Sjögren's Trial, Shares Plunge 14%7ACTUActuate Therapeutics, Inc.Actuate Therapeutics Names Konik as Underwriter, Discloses Newbridge Conflicts in $47.1M Offering7RNAAtrium Therapeutics, Inc.Atrium Therapeutics Raises $50M in Private Placement Near 52-Week Low8ARGXARGENX SEargenx: FB102 Phase 2 Win in Celiac, But UNITY Sjögren's Study Fails7BHVNBiohaven Ltd.Biohaven Licenses IgG Degrader Platform to Ono Pharma for Japan and Asia
Wed, Oct 75 events
8VALNValneva SEUK Revokes Marketing Authorization for Valneva's Chikungunya Vaccine8LSTALisata Therapeutics, Inc.Lisata Seeks Stockholder Approval for Marea Conversion, Reverse Split to Avoid Nasdaq Delisting7DCOYDecoy Therapeutics Inc.Decoy Files S-1 to Register Resale of 2.37 Million Shares Underlying Armistice Warrants7GNTAGenenta Science S.p.A.Milan Court Denies Bid to Suspend ATC Capital Increase7VTVTvTv Therapeutics Inc.FDA Grants Orphan Drug Designation to vTv's HPPD for Sickle Cell Disease
Biotech companies on Wiseek (607)
Each company page tracks that company's SEC filings, news and market data.
AAPGAARDABCLABEOABOSABSIABUSABVCABVXACADACETACHVACIUACLXACOGACRVACTUACXPADAGADCTADILADMAADPTADTXADXNAGENAGIOAGMBAIXCAKBAAKTSAKTXALDXALECALGSALLOALLRALMSALNYALTALXOALZNAMLXANABANIXANLANNXANROANTXANVSAPGEAPLMAPLSAPMAPREAPVOARCTARDXARGXARQTARTLARTVARVNARWRASBPASMBASNDATAIATHEATOSATRAATXIATYRAUPHAURAAUTLAVBPAVIRAVLNAVTXAVXLAXSMBBIOBBOTBCABBCAXBCDABCLIBCRXBCTXBCYCBDRXBDTXBEAMBGMSBHVNBIVIBLRXBLTEBMEABMRNBNTCBNTXBOLDBOLTBRNSBRTXBTAIBYSICABACADLCALCCAMPCAPRCBIOCBUSCCCCCDIOCDTCDXSCELCCELUCELZCGEMCGENCGONCGTXCHRSCINGCLDXCLGNCLLSCLNNCLRBCLYMCMMBCMNDCMPXCNSPCNTACNTBCNTNCNTXCOAGCOCPCOGTCORTCOYACPRXCRBPCRBUCRDFCRISCRMDCRNXCRSPCRVOCRVSCSBRCTMXCTNMCTXRCUECURXCVKDCYCNCYPHCYTKDAREDAWNDBVTDCOYDFTXDMACDMRADNADNLIDNTHDOMHDRMADRTSDRUGDSGNDTILDWTXDYAIDYNEDITEDSAEIKNELABELDNELOXELTXELVNEMMAENGNENLVENSCENTAENTXENVBENZNENZNDEPRXEQERASERNAESLAEVAXEVFMEVGNEVMNEWTXEXELEXOZEYPTFATFATEFBIOFBLGFBRXFDMTFENCFHTXFLNAFOLDFRMMFTREFULCGALTGANXGDTCGENBGERNGHRSGLMDGLPGGLSIGLUEGMABGNLXGNPXGNTAGOSSGOVXGPCRGRCEGRDXGRIGRMLGRTXGTBPGUTSGYREHALOHCWBHELPHOTHHOWLHRMYHRTXHUMAHURAHYFTHYPDIBIOIBRXICCCICUIDYAIFRXIKTIMAIMCRIMMPIMMXIMNMIMNNIMRNIMRXIMTXIMUXIMVTINABINBXINCYINDPINKTINMINMBINOINSMINTSINVAIONSIOVAIPHAIPSCIRDIRONIVAIVVDJAGXJANXJAZZJBIOJSPRJUNSKALVKLRAKNSAKODKPRXKPTIKROSKRROKRYSKTTAKURAKYMRKYNBKYTXKZIAKZRLABTLBRXLEGNLENZLEXXLGNDLGVNLIMNLITSLIXTLNAILONALPCNLQDALRMRLSTALTRNLXEOLXRXLYELLYRAMANEMAZEMBIOMBRXMBXMCRBMDGLMDWDMDXGMENSMESOMGNXMGTXMGXMIRMMISTMITIMLECMLTXMLYSMNKDMNOVMNPRMOLNMPLTMREOMRKRMRNAMRVIMSLEMTVANAGENAMSNAUTNBPNBTXNCELNCNANERVNEUPNGENNGNENKTRNKTXNMRANRIXNRSNNRXPNTHINTLANTRBNUVBNUVLNVAXNVCTNVONWBONXTCOABIOBIOOCGNOCSOCULODTXOKUROKYOOLMAOMERONCONCOONCYORGSORICORKAORMPOSRHOTLCOTLKOVIDPALIPASGPBMPBYIPCSAPCVXPDSBPEPGPGENPHARPHATPHIOPHVSPLRXPLRZPLURPLYXPMCBPMNPMVPPPBTPPCBPRAXPRLDPRMEPROKPRQRPRTAPRTCPSTVPTCTPTGXPTIXPULMPVCTPVLAPYPDPYXSQCLSQNCXQNRXQSIQTTBQURERADXRANIRAPPRARERCKTRCUSREGNREPLREVBRGNXRIGLRLAYRLMDRLYBRNARNACRNAZRNTXRNXTROIVRPRXRVMDRVPHRXRXRYTMRZLTSABSSANASCNISEERSEPNSGMOSGMTSILOSIONSKYESLDBSLGLSLNSLNOSLSSLXNSMMTSNDXSNGXSNSESNTISPRBSPRCSPROSPRYSPTXSRPTSRRKSRZNSTOKSTROSTTKSVRASXTPSYBXSYRETAOXTARATARSTBPHTCRTTCRXTECHTECXTELOTENXTERNTGTXTILTLPPFTLSATLXTNGXTNXPTNYATPSTTRAWTRDATRVITSHATTRXTVGNTVRDTVTXTYRAUNCYUPBURGNUTHRVALNVANIVCELVCYTVERAVERUVIRVIVSVKTXVNDAVORVRAXVRCAVRDNVRTXVSTMVTGNVTVTVXRTVYGRVYNEWHWKWVEXBIOXBITXCURXENEXERSXFORXLOXNCRXOMAXRTXXTLBYDESZBIOZIVOZLABZNTLZSQRZURAZVRAZYME
How Wiseek picks and scores these
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a biotech company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
See the full Healthcare sector feed.